about
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Ico...
Read More
150.59
5.20
(3.58%)
1.7M
XNAS Volume
XNAS 06 Feb, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Icon PLC is on 19 Feb 2026 for the purpose of Icon PLC Fourth Quarter Earnings Results for 2025
See details
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors
View Similar
Embed DVM
Icon PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..